PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Finlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.\', \'Center of Molecular Immunology, P.O. Box 16040, 216 St., Havana, Cuba.\', \'Laboratory of Synthetic and Biomolecular Chemistry, Faculty of Chemistry, University of Havana, Zapata y G, Havana 10400, Cuba.\', \'National Civil Defense Research Laboratory, Mayabeque 32700, Cuba.\', \'Shanghai Fenglin Glycodrug Promotion Center, Shanghai 200032, China.\', \'Center for Genetic Engineering and Biotechnology, Ave 31 e/158 y 190, Havana 10600, Cuba.\', \'Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081HV, The Netherlands.\', \'Institute of Biomolecular Chemistry, National Research Council (CNR), Pozzuoli 80078, Napoli, Italy.\', \'Centre de Biophysique MolĂ©culaire, CNRS UPR 4301, rue Charles Sadron F-45071, OrlĂ©ans, Cedex 2, France.\', \'Chengdu Olisynn Biotech. Co. Ltd., and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acschembio.1c00272
?:hasPublicationType
?:journal
  • ACS chemical biology
is ?:pmid of
?:pmid
?:pmid
  • 34219448
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.57
?:rankingScore_hIndex
  • 83
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all